Cargando…

Immunomodulation of COVID‐19 severity by helminth co‐infection: Implications for COVID‐19 vaccine efficacy

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), an emerging virus in late 2019 causing coronavirus disease 2019 (COVID‐19), has caused a catastrophic effect, resulting in an unprecedented global crisis. The immunopathology of COVID‐19 appears to be clearly associated with a dysregulate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akelew, Yibeltal, Andualem, Henok, Ebrahim, Endris, Atnaf, Aytenew, Hailemichael, Wasihun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926508/ https://www.ncbi.nlm.nih.gov/pubmed/34861106 http://dx.doi.org/10.1002/iid3.573

Ejemplares similares

Neopterin: A Promising Candidate Biomarker for Severe COVID-19
por: Hailemichael, Wasihun, et al.
Publicado: (2021)

Immunoglobulin G2 Antibody as a Potential Target for COVID-19 Vaccine
por: Andualem, Henok, et al.
Publicado: (2020)

Hematological Profiles and Clinical Outcome of COVID-19 Among Patients Admitted at Debre Markos Isolation and Treatment Center, 2020: A Prospective Cohort Study
por: Atnaf, Aytenew, et al.
Publicado: (2022)

Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19
por: Getu, Sisay, et al.
Publicado: (2021)

COVID-19 pandemic: current knowledge about the role of pets and other animals in disease transmission
por: Kiros, Mulugeta, et al.
Publicado: (2020)

Association of Cytotoxic T-Lymphocyte Antigen-4 Gene Polymorphism with Type 1 Diabetes Mellitus: In silico Analysis of Biological Features of CTLA-4 Protein on Ethiopian Population
por: Ebrahim, Endris, et al.
Publicado: (2022)

Helminth Immunomodulation in Autoimmune Disease
por: Smallwood, Taylor B., et al.
Publicado: (2017)

Prevalence and Determinants of Pre-Cancerous Cervical Lesion and Human Papillomavirus Among HIV-Infected and HIV-Uninfected Women in North-West Ethiopia: A Comparative Retrospective Cross-Sectional Study
por: Kiros, Mulugeta, et al.
Publicado: (2021)

Helminths and COVID-19 susceptibility, disease progression, and vaccination efficacy
por: Whitehead, Bradley, et al.
Publicado: (2022)

Harnessing the Helminth Secretome for Therapeutic Immunomodulators
por: Ditgen, Dana, et al.
Publicado: (2014)

Immunomodulation in COVID-19
por: Ingraham, Nicholas E, et al.
Publicado: (2020)

Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art
por: Zhang, Yinhua, et al.
Publicado: (2020)

Blood Transfusion Complications and Associated Factors Among Blood-Transfused Adult Patients at Debre Markos Comprehensive Specialized Hospital, Ethiopia: A Cross Sectional Study
por: Muche, Yalew, et al.
Publicado: (2023)

Helminth defence molecules—immunomodulators designed by parasites!
por: Robinson, Mark W., et al.
Publicado: (2013)

A Role for Epitope Networking in Immunomodulation by Helminths
por: Homan, E. Jane, et al.
Publicado: (2018)

Immunomodulation by Helminths: Intracellular Pathways and Extracellular Vesicles
por: Zakeri, Amin, et al.
Publicado: (2018)

COVID-19 and immunomodulation in IBD
por: Neurath, Markus F
Publicado: (2020)

Immunomodulation and immunotherapeutics of COVID-19
por: Garg, Sourbh Suren, et al.
Publicado: (2021)

COVID-19 and gut immunomodulation
por: Roy, Koushik, et al.
Publicado: (2021)

Mothers’ health care-seeking behavior and associated factors for common childhood illnesses in Ethiopia: A systematic review and meta-analysis
por: Merkeb Alamneh, Yoseph, et al.
Publicado: (2022)

Immunomodulation and Immune Escape Strategies of Gastrointestinal Helminths and Schistosomes
por: Wiedemann, Marie, et al.
Publicado: (2020)

Trichinella-induced immunomodulation: Another tale of helminth success
por: Bruschi, F., et al.
Publicado: (2022)

Efficacy of phytochemicals as immunomodulators in managing COVID-19: a comprehensive view
por: Bhattacharya, Sonali, et al.
Publicado: (2021)

The role of micro, small and medium enterprises (MSMEs) to the sustainable development of sub-Saharan Africa and its challenges: a systematic review of evidence from Ethiopia
por: Endris, Ebrahim, et al.
Publicado: (2022)

Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases
por: Lucas, Kurt, et al.
Publicado: (2021)

Effects of nutrients on immunomodulation in patients with severe COVID-19: Current knowledge
por: da Costa, Bruna Teixeira, et al.
Publicado: (2022)

Immunopathogenesis of COVID-19 and early immunomodulators
por: Lee, Kyung-Yil, et al.
Publicado: (2020)

Cytokine Storm and Immunomodulation in COVID-19
por: Rangappa, Pradeep
Publicado: (2021)

Combining immunomodulators and antivirals for COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology
por: Reinholz, Markus, et al.
Publicado: (2021)

Will helminth co-infection modulate COVID-19 severity in endemic regions?
por: Bradbury, Richard S., et al.
Publicado: (2020)

Magnitude of anemia and associated factors among children aged 6–59 months at Debre Markos referral hospital, Northwest Ethiopia: a hospital-based cross-sectional study
por: Alamneh, Yoseph Merkeb, et al.
Publicado: (2021)

Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules?
por: Cotton, Sophie, et al.
Publicado: (2012)

P29 - Intestinal helminth Enterobius vermicularis as an immunomodulator factor
por: Patsantara, Giannoula, et al.
Publicado: (2014)

The interplay of helminthic neuropeptides and proteases in parasite survival and host immunomodulation
por: Kaur, Rimanpreet, et al.
Publicado: (2022)

Immunomodulation Effect of Convalescent Plasma Therapy in Severe – Critical COVID-19 Patients
por: Fitriah, Munawaroh, et al.
Publicado: (2023)

Safety of an immunomodulator Mycobacterium w in COVID-19
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2020)

Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes
por: Mauvais-Jarvis, Franck, et al.
Publicado: (2020)

Combining Antivirals and Immunomodulators to Fight COVID-19
por: Feuillet, Vincent, et al.
Publicado: (2021)

COVID-19 and immunomodulator/immunosuppressant use in dermatology
por: Price, Kyla N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8a9ic41s82nooren6o4sq114tt